» Articles » PMID: 23988844

Animal Versus Human Oral Drug Bioavailability: Do They Correlate?

Overview
Journal Eur J Pharm Sci
Specialties Chemistry
Pharmacology
Date 2013 Aug 31
PMID 23988844
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Oral bioavailability is a key consideration in development of drug products, and the use of preclinical species in predicting bioavailability in human has long been debated. In order to clarify whether any correlation between human and animal bioavailability exist, an extensive analysis of the published literature data was conducted. Due to the complex nature of bioavailability calculations inclusion criteria were applied to ensure integrity of the data. A database of 184 compounds was assembled. Linear regression for the reported compounds indicated no strong or predictive correlations to human data for all species, individually and combined. The lack of correlation in this extended dataset highlights that animal bioavailability is not quantitatively predictive of bioavailability in human. Although qualitative (high/low bioavailability) indications might be possible, models taking into account species-specific factors that may affect bioavailability are recommended for developing quantitative prediction.

Citing Articles

In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions.

Mohammadi S, Eslami S, Jones L, Gorbet M Drug Deliv Transl Res. 2024; .

PMID: 39636534 DOI: 10.1007/s13346-024-01746-z.


A randomized, placebo-controlled first-in-human study of oral TQS-168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect.

Hannestad J, Smith S, Lam A, Hurt J, Harada N, Kim R Clin Transl Sci. 2024; 17(11):e70064.

PMID: 39535924 PMC: 11559592. DOI: 10.1111/cts.70064.


Liver-on-chips for drug discovery and development.

Mehta V, Karnam G, Madgula V Mater Today Bio. 2024; 27:101143.

PMID: 39070097 PMC: 11279310. DOI: 10.1016/j.mtbio.2024.101143.


Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.

Guengerich F Pharmacol Rev. 2024; 76(6):1104-1132.

PMID: 39054072 PMC: 11549934. DOI: 10.1124/pharmrev.124.001173.


Trust your gut: Establishing confidence in gastrointestinal models - An overview of the state of the science and contexts of use.

Debad S, Allen D, Bandele O, Bishop C, Blaylock M, Brown P ALTEX. 2024; 41(3):402-424.

PMID: 38898799 PMC: 11413798. DOI: 10.14573/altex.2403261.


References
1.
Chiou W, Buehler P . Comparison of oral absorption and bioavailablity of drugs between monkey and human. Pharm Res. 2002; 19(6):868-74. DOI: 10.1023/a:1016169202830. View

2.
Grass G, Sinko P . Physiologically-based pharmacokinetic simulation modelling. Adv Drug Deliv Rev. 2002; 54(3):433-51. DOI: 10.1016/s0169-409x(02)00013-3. View

3.
Sietsema W . The absolute oral bioavailability of selected drugs. Int J Clin Pharmacol Ther Toxicol. 1989; 27(4):179-211. View

4.
Chiou W, Jeong H, Chung S, Wu T . Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res. 2000; 17(2):135-40. DOI: 10.1023/a:1007552927404. View

5.
Cao X, Gibbs S, Fang L, Miller H, Landowski C, Shin H . Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res. 2006; 23(8):1675-86. DOI: 10.1007/s11095-006-9041-2. View